Published in Math Biosci on January 04, 2010
Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users. PLoS One (2011) 0.83
Acceptance of referral for partners by clients testing positive for human immunodeficiency virus. HIV AIDS (Auckl) (2013) 0.79
Optimizing an HIV testing program using a system dynamics model of the continuum of care. Health Care Manag Sci (2015) 0.78
Conflicts of interest during contact investigations: a game-theoretic analysis. Comput Math Methods Med (2014) 0.76
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Concurrent partnerships and the spread of HIV. AIDS (1997) 10.73
Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology (2007) 3.06
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med (2005) 2.68
Interpretation of cost-effectiveness analyses. J Gen Intern Med (1998) 1.85
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med (2007) 1.76
Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. J Acquir Immune Defic Syndr (2001) 1.33
Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis. J Health Econ (2003) 1.15
Quantitative guidelines for communicable disease control program: a complete synthesis. Biometrics (1974) 1.10
Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention. Int J STD AIDS (2011) 1.07
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Health Technol Assess (2006) 1.04
Dynamic resource allocation for epidemic control in multiple populations. IMA J Math Appl Med Biol (2002) 1.02
Optimal mix of screening and contact tracing for endemic diseases. Math Biosci (2007) 0.99
Resource allocation for epidemic control over short time horizons. Math Biosci (2001) 0.98
Contact tracing to control infectious disease: when enough is enough. Health Care Manag Sci (2007) 0.95
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics. Oper Res (2008) 0.83
Quantitative guidelines for communicable disease control programs. Biometrics (1971) 0.82
Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States. Am J Manag Care (2001) 0.81
Effects of treatment and prevalence-dependent recruitment on the dynamics of a fatal disease. IMA J Math Appl Med Biol (1996) 0.81
A simulation model of AIDS in San Francisco: II. Simulations, therapy, and sensitivity analysis. Math Biosci (1991) 0.81
Are organic foods safer or healthier than conventional alternatives?: a systematic review. Ann Intern Med (2012) 5.45
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med (2010) 2.71
The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med (2012) 2.34
Cost-effectiveness of strategies for diagnosing pulmonary embolism among emergency department patients presenting with undifferentiated symptoms. Ann Emerg Med (2010) 2.19
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med (2007) 1.76
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med (2011) 1.62
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48
Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med (2010) 1.41
The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS (2011) 1.14
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology (2010) 1.07
A little planning goes a long way: multilevel allocation of HIV prevention resources. Med Decis Making (2007) 1.04
Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Med Decis Making (2010) 1.04
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS One (2012) 1.03
Dynamic resource allocation for epidemic control in multiple populations. IMA J Math Appl Med Biol (2002) 1.02
Potential population health outcomes and expenditures of HIV vaccination strategies in the United States. Vaccine (2009) 1.01
Optimal mix of screening and contact tracing for endemic diseases. Math Biosci (2007) 0.99
Contact tracing to control infectious disease: when enough is enough. Health Care Manag Sci (2007) 0.95
Optimal link removal for epidemic mitigation: a two-way partitioning approach. Math Biosci (2011) 0.87
The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men. Med Decis Making (2008) 0.87
Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies. Biosecur Bioterror (2006) 0.85
HIV epidemic control-a model for optimal allocation of prevention and treatment resources. Health Care Manag Sci (2013) 0.84
Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces (Providence) (2011) 0.84
Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? Clin Infect Dis (2012) 0.84
Inferring model parameters in network-based disease simulation. Health Care Manag Sci (2011) 0.83
Modeling the logistics of response to anthrax bioterrorism. Med Decis Making (2008) 0.83
Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics. Oper Res (2008) 0.83
Too much of a good thing? When to stop catch-up vaccination. Med Decis Making (2013) 0.82
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Ann Intern Med (2016) 0.80
Value of quantitative D-dimer assays in identifying pulmonary embolism: implications from a sequential decision model. Acad Emerg Med (2006) 0.79
Modeling complex medical decision problems with the Archimedes model. Ann Intern Med (2005) 0.77
Are organic foods safer or healthier? Ann Intern Med (2013) 0.76
A knowledge representation of local pandemic influenza planning models. AMIA Annu Symp Proc (2007) 0.75